Amendoeira Fabio Coelho, Frutuoso Valber Silva, Zanon Cristiane, Chedier Luciana Moreira, Figueiredo Maria Raquel, Kaplan Maria Auxiliadora Coelho, Bandeira-Melo Christianne, Bozza Patrícia Torres, Castro-Faria-Neto Hugo Caire
Laboratório de Imunofarmacologia, Departamento de Fisiologia e Farmacodinâmica, Rio de Janeiro, Brazil.
Biol Pharm Bull. 2005 Jun;28(6):1010-5. doi: 10.1248/bpb.28.1010.
Nidularium procerum LINDMAN, a common bromeliaceae from the Brazilian flora, remains poorly studied regarding its chemical and pharmacological properties. We have recently published that N. procerum has potent analgesic and anti-inflammatory activities. In the present work, we have investigated potential mechanisms involved in the anti-inflammatory effects of N. procerum aqueous extract on lipopolysaccharide (LPS)-, platelet activating factor (PAF)- or formyl-methionyl-leucyl-phenylalanine (fMLP)-induced pleurisy models of inflammation. We found that the aqueous extract of N. procerum leaves (leaf aqueous extract; LAE) inhibits the neutrophil migration, production of inflammatory cytokines interleukin-1 and -6 (IL-1 and IL-6) and the generation of prostaglandin E2 (PGE2) in LPS-induced pleural inflammation in mice. Such inhibitory effect of N. procerum on PGE2 generation was tightly correlated to the inhibition of formation of new cytoplasmic lipid bodies within recruited leukocytes. N. procerum also blocked the in vivo neutrophil influx induced by injection of PAF or fMLP into the mouse pleural cavity and directly inhibited PAF-induced neutrophil chemotaxis in vitro. The data obtained in this study indicate that N. procerum LAE exerts its anti-inflammatory effects by interfering with the capacity of the host to respond to injury at different levels. Among the different functions affected by N. procerum LAE, lipid body formation, PGE2 and cytokine production and neutrophil chemotaxis are readily evidenced in relevant surrogate models. The N. procerum bioactive profile makes it an attractive candidate for future development as a drug or phytomedicine.
长叶鸟巢凤梨(Nidularium procerum LINDMAN)是巴西植物区系中一种常见的凤梨科植物,但其化学和药理特性的研究仍很匮乏。我们最近发表研究称,长叶鸟巢凤梨具有强大的镇痛和抗炎活性。在本研究中,我们探究了长叶鸟巢凤梨水提取物对脂多糖(LPS)、血小板活化因子(PAF)或甲酰甲硫氨酰亮氨酰苯丙氨酸(fMLP)诱导的胸膜炎炎症模型产生抗炎作用的潜在机制。我们发现,长叶鸟巢凤梨叶片的水提取物(叶水提取物;LAE)可抑制小鼠LPS诱导的胸膜炎症中嗜中性粒细胞的迁移、炎性细胞因子白细胞介素-1和-6(IL-1和IL-6)的产生以及前列腺素E2(PGE2)的生成。长叶鸟巢凤梨对PGE2生成的这种抑制作用与募集的白细胞内新的细胞质脂滴形成的抑制密切相关。长叶鸟巢凤梨还可阻断向小鼠胸腔注射PAF或fMLP诱导的体内嗜中性粒细胞流入,并在体外直接抑制PAF诱导的嗜中性粒细胞趋化性。本研究获得的数据表明,长叶鸟巢凤梨LAE通过在不同水平干扰宿主对损伤的反应能力来发挥其抗炎作用。在长叶鸟巢凤梨LAE影响的不同功能中,脂滴形成、PGE2和细胞因子产生以及嗜中性粒细胞趋化性在相关替代模型中很容易得到证实。长叶鸟巢凤梨的生物活性特征使其成为未来开发药物或植物药的有吸引力的候选物。